Two-year durability of REBYOTA (TM) (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections
Open forum infectious diseases（2023）
关键词
Clostridioides difficile infection, live biotherapeutic product, durable response, microbiome, bile acids
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要